Pharmacology, Toxicology and Pharmaceutical Science
Disease Model
100%
Inflammatory Bowel Disease
100%
Colitis
100%
Dextran Sulfate
80%
2,4,6-Trinitrobenzenesulfonic Acid
60%
Neoplasm
40%
Chemokine
40%
Colorectal Carcinoma
40%
Azoxymethane
40%
Inflammation
20%
Cytokine
20%
C57BL 6 Mouse
20%
Phosphate Buffered Saline
20%
Cancer Model
20%
Disease Activity
20%
Chronic Inflammation
20%
Antiinflammatory Agent
20%
Dextran Sulfate Sodium-Induced Colitis
20%
Keyphrases
Therapeutic Agents
100%
Inflammatory Bowel Disease
100%
Disease Model
100%
Chemokine (C-C motif) Ligand 2 (CCL2)
100%
Dextran Sulfate Sodium-induced Colitis
27%
2,4,6-trinitrobenzene Sulfonic Acid
27%
Colorectal Cancer
18%
Tumor
18%
Chemokines
18%
T Cells
18%
Immune Response
9%
Inflammation
9%
Inflammatory Cytokines
9%
Cell-to-cell
9%
Lymphoid Tissue
9%
Colon
9%
C57BL
9%
Phosphate-buffered Saline
9%
Monocytes
9%
Dendritic Cells
9%
Cytokine Levels
9%
Peripheral Tissues
9%
Immune Cells
9%
Colitis Model
9%
DSS-induced Colitis
9%
Memory T Cells
9%
Disease Activity
9%
Cancer Model
9%
Colitis
9%
Chronic Inflammation
9%
Dextran Sulfate Sodium
9%
Azoxymethane
9%
Anti-inflammatory Agents
9%
Inflammation-associated Cancer
9%
Murine Colitis
9%
Azoxymethane/dextran Sodium Sulfate
9%
Immunology and Microbiology
Inflammatory Bowel Disease
100%
CCL2
100%
Colitis
54%
Chemokine
18%
T Cell
18%
Immune Response
9%
Immunocompetent Cell
9%
Colon
9%
Inflammatory Cytokine
9%
Dendritic Cell
9%
C57BL 6 Mouse
9%
Decision Support System
9%
Memory T Cell
9%